And then there were two

A cardiologist and a city health official lead the pack of potential FDA commissioners

Bob Grant
Bob Grant

Bob Grant is Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.

View full profile.


Learn about our editorial policies.

Jan 22, 2009
The blogosphere has been alight this week with the news that only two candidates remain in the running to become President Barack Obama's new FDA commissioner: Joshua Sharfstein, Baltimore's city health commissioner and linkurl:Robert Califf,;http://www.dukemedicine.org/Leadership/Administration/CaliffRobert%20 Duke University's vice chancellor for clinical research.
Califf
linkurl:Peter Pitts,;http://www.cmpi.org/about-us/founders/peter-pitts/ president of the Center for Medicine in the Public Interest (CMPI) and former FDAstaffer, confirmed those rumors, both on linkurl:DrugWonks.com;http://www.drugwonks.com/blog_post/show/6571 -- CMPI's blog -- and when I called him yesterday. Pitts, who has advised the Obama transition team, said that Sharfstein and Califf were the only two names receiving serious consideration.The gravity of Obama's choice seems to increase day by day. Yesterday, the Government Accountability Office linkurl:placed;http://www.gao.gov/products/GAO-09-271 the FDA on a list of "high-risk" areas of the federal government, to attract the attentions of legislators. "FDA needs to, among other things, improve the data it uses to manage the foreign drug inspection program, conduct more...
Sharfstein



Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?